Health Catalyst Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Holmusk builds real-world data and analytics products for neuropsychiatry, including NeuroBlu Data (de-identified patient records mapped from U.S. electronic health records) and NeuroBlu Analytics, an evidence engine that lets researchers build patient cohorts and run observational studies.
AI & Machine LearningData & InfrastructureDigital HealthMental HealthNew York, US
Nawal Kishore Roy(Executive Officer, Director, Promoter)Nawal Roy(Founder)inTramontin Anthony David(Executive Officer, Director)Chik Wai Chiew(Director)Michael Weintraub(Director)
Board seatCharles Andrew Boorady· per SEC Form D
Co-investorsOptum Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.